We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Batm Advanced Communications Ld | LSE:BVC | London | Ordinary Share | IL0010849045 | ORD ILS0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.275 | -1.43% | 18.925 | 18.40 | 19.45 | - | 171,375 | 16:35:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Communications Services, Nec | 122.83M | -193k | -0.0004 | -480.00 | 83.72M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/11/2023 10:10 | Further investigation reveals Adaltis actually do have a respiratory virus PCR panel test that went commercial (and CE approval) at the end of last year (2022) according to BATM year end results March 2023. Novacyt are shouting loud about their capability in this area at the moment hence their share price sharply up! | resistance1 | |
28/11/2023 08:38 | Novacyt SA, a clinical diagnostics specialist, said it has won UK approval for its multiplex PCR test for the detection of winter viruses, including SARS-CoV-2, influenza A and B, and respiratory syncytial virus (RSV). This PCR testing company got UK approval recently for a winter viruses test incl swine flu. Shares, due to the outbreak in China, have risen 50% in the last 3 trading days. Does anyone know if Adaltis can do this? I know there will be a Ador panel test in a year or two, but we are talking old school PCR not molecular here. | resistance1 | |
27/11/2023 14:35 | We are apparently some way from having agreement on a "lite" product for commercial markets but with multiple attacks on state assets and on the 10 friendly countries that IDF has agreed can be supplied i agree would be good to see further uptake and some diversified income streams..i guess whilst the core cyber software is fully developed one might need significant integration work to incorporate in foreign systems ..lets hope many irons are in the fire.Same with Edgility they talked of a number of ongoing trials ..these things can take time but time is ticking on. | kooba | |
27/11/2023 12:11 | I am surprised we haven't seen more than the one cyber contract announcement as a result of the conflict so far. Or contracts for other Government departments. | resistance1 | |
27/11/2023 10:31 | Situation in Israel on cyber attacks.https://www. | kooba | |
27/11/2023 10:28 | https://news.sky.com | kooba | |
23/11/2023 14:03 | Bit of a catch 22 i guess the big boys pay big bucks once they can see the market adopting the technology and the clientele is widening unfortunately that relies on closing sales which is something BATM seem under resourced in. Just hope opportunities are not missed forever by lack of sales people.The big clue in last presentation was a possible US acquisition with sales to feed into US blue chips..nothing more has come through on that yet but for Egility probably it makes good sense.Can't help the concern that we are not the only ones with ready products in these markets and that we get overtaken by the competition.We need clear path to commercial traction in both edge and cyber...pretty soon i guess.Same can be said for ADOR ..markets don't wait forever! And as someone else pointed out with Oxford Nanopore they are not the only player in molecular diagnostics. | kooba | |
23/11/2023 08:58 | The Palo Alto purchase is at a good price, as it fits well with their offering. You would think Celare would also be great fits for defence tech companies like Israel’s Elbit Systems who clearly can’t be short of money at the moment. I am surprised sensible approaches have not been made as yet for Celare or for Edgility for that matter. I just hope BATM is on the radar | resistance1 | |
22/11/2023 17:58 | Interesting in such a trouble background for technology especially in Israel that there is such encouraging activity.Certainly makes the market value here look somewhat over cautious.Would be good if there was some more order news from any division before the year end.It sounded like much was going on with Edgility but seems slow in closing new contracts. | kooba | |
22/11/2023 17:54 | More commercial application but again it does show the potential value in the cyber division if they can grow a diversified customer base and launch a successful commercial offering I guess.https://www.ve | kooba | |
22/11/2023 17:50 | Fundraise for Israeli cyber business ..raised $35m for a start up ..wonder what a business with proven product and growing revenues might be worth ? Does look like it is hunting in the same markets as Batm but I am told that in terms of the evolution of cyber attacks no one can touch us. No expert but realise it is a big and growing market...as always would be good to see more diverse traction from our division.https://en. | kooba | |
20/11/2023 17:23 | This is really gaining traction and one area I am familiar with is virtual try ones for Glasses. The low latency means that you can not just see what the glasses look like on your face but you can turn your head from side to side and see the overall effect. Obviously this is a big “ditto” for numerous other applications. The applications are endless. I was involved with an eye glass retailer and a facial recognition company a few years back and the hick up they had would have been sorted out with edge computing but it was not available at that time. | fse | |
17/11/2023 17:16 | Interesting article from Telco systems X thread | fse | |
16/11/2023 11:19 | A troll is a being in Nordic folklore, including Norse mythology. In Old Norse sources, beings described as trolls dwell in isolated areas of rocks, mountains, or caves, live together in small family units, and are rarely helpful to human beings. | nellyb | |
15/11/2023 21:09 | Barry, has the rebalancing finished here now? | kemche | |
15/11/2023 18:58 | I think resistance is being ironic, volsung. You didn’t provide any input, or output for that matter. Nothing of value or consequence whatsoever. Just a complete waste of digital space. De rien, my itchy sphincter | echoridge | |
15/11/2023 17:07 | De rien resistance1 | volsung | |
15/11/2023 17:02 | Thanks Volsung it's good to get input from historical investors. Appreciate your continuing interest. | resistance1 | |
15/11/2023 15:53 | I used to have an investment here FSE Sold up in May | volsung | |
15/11/2023 15:45 | Volsung you dont have any investment in Israeli companies in the first place so why say anything at all. | fse | |
15/11/2023 14:58 | I’m divesting from all Israeli companies. Think there might be a few others doing the same | volsung | |
15/11/2023 14:53 | The relevance of this is that BATM handle the cyber for the IDF and Edgility bundle cyber in their OS architecture | fse | |
13/11/2023 13:00 | Adaltis MEDICA 2023, Dusseldorf 13-16 November 2023 They will be presenting the latest developments and products covering: - Biochemistry POC Cartridge Solution - New NGS lab solutions: EXTRAlab NGS prep - Molecular Diagnostics testing line: - Molecular diagnostic kit/panels and - Automated systems for extraction/purificat and PCR set-up : EXTRAlab - AMPLiLab -eLAB Blood Bank Assays supported by microELISA analysers. | resistance1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions